Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPIAL4E | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | PPP1R12C | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | CYTH3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | P4HA3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | ZNF112 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | MFSD3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | PRKD2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | PSD | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | CTSS | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | CENPC | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |